• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Amy Abernethy on Improving Data Usage at the Point of Care

Video

Data needs to be more organized so it is more available and useful at the point of care, said Amy Abernethy, MD, PhD, the chief medical officer, chief scientific officer, and senior vice president of oncology at Flatiron Health.

Transcript (slightly modified)

With all the data now available, how can we ensure that it is used at the point of care to improve care delivery?

There’s so much data available. First of all, it needs to be cleaned up, so that by the time the data gets back to doctor and patient, it’s something that’s sensible. So, in order to make it available and useful for a point of care, it needs to be cleaned up and put into order. It needs to be analyzed and information needs to be presented to doctors and patients directly in the electronic health record or in dashboards that summarize, for example, what treatments patients have been receiving and how patients that look like this person sitting in front of me, have fared on Treatment A versus Treatment B.

So, that set of activities which include data, cleaning and organization, as well as getting to the point of having analyses we can rely on and being presented in dashboards and other methods to make is easy at point-of-care, is going to be the way that data starts to change care. The first steps are there but I think we’ve got a long way to go.

Related Videos
Experts warn that ICHRAs could either stabilize or destabilize the individual market, depending on which workers employers shift into these plans.
Aleata Postell, SVP of pharmacy business development, CenterWell Pharmacy
ASCO GI 2026 Recap
Jo Varshney, PhD, DVM, CEO and founder of VeriSIM Life
Dr Marco del Riccio
Bhavana (Tina) Bhatnagar, DO, West Virginia University Cancer Institute at Wheeling Hospital
Dr Debra Patt
Dr Marco del Riccio
Where patients live may shape outcomes in hypertrophic cardiomyopathy, with SDOH linked to higher risks of heart failure and arrhythmias.
Dr Yara Abdou
© 2026 MJH Life Sciences
AJMC®
All rights reserved.